Literature DB >> 18593377

Evaluation of an orthogonal pooling strategy for rapid high-throughput screening of proteases.

Nuzhat Motlekar1, Scott L Diamond, Andrew D Napper.   

Abstract

Orthogonal pooling was evaluated as a strategy for the rapid screening of multiple cysteine and serine proteases against large compound libraries. To validate the method the human cysteine protease cathepsin B was screened against a library of 64,000 individual compounds and also against the same library mixed 10 compounds per well. The orthogonal pooling method used resulted in each compound being present in two wells, mixed with a different set of nine other compounds in each location. Thus hits were identified based on activity in both locations, avoiding the need for retesting of each component of active mixtures. Hits were tested in dose-response both in the dithiothreitol (DTT)-containing buffer used in the primary HTS and in buffer containing cysteine in place of DTT to rule out artifacts due to oxidative inactivation of the enzyme. Comparison of the confirmed actives from single-compound and mixture screening showed that mixture screening identified all of the actives from single-compound HTS. Based on these results the orthogonal pooling strategy has been used successfully to rapidly screen several cysteine and serine proteases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18593377      PMCID: PMC2971631          DOI: 10.1089/adt.2007.110

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  14 in total

1.  Strategic pooling of compounds for high-throughput screening.

Authors:  M Hann; B Hudson; X Lewell; R Lifely; L Miller; N Ramsden
Journal:  J Chem Inf Comput Sci       Date:  1999 Sep-Oct

Review 2.  Apoptotic pathways: involvement of lysosomal proteases.

Authors:  Boris Turk; Veronica Stoka; Jerica Rozman-Pungercar; Tina Cirman; Gabriela Droga-Mazovec; Kristina Oresić; Vito Turk
Journal:  Biol Chem       Date:  2002 Jul-Aug       Impact factor: 3.915

3.  Statistical evaluation of a self-deconvoluting matrix strategy for high-throughput screening of the CXCR3 receptor.

Authors:  Sandrine Ferrand; Andres Schmid; Caroline Engeloch; J Fraser Glickman
Journal:  Assay Drug Dev Technol       Date:  2005-08       Impact factor: 1.738

Review 4.  Lysosomal cysteine proteases: structural features and their role in apoptosis.

Authors:  Veronika Stoka; Boris Turk; Vito Turk
Journal:  IUBMB Life       Date:  2005 Apr-May       Impact factor: 3.885

5.  Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein.

Authors:  Kathryn Schornberg; Shutoku Matsuyama; Kirsten Kabsch; Sue Delos; Amy Bouton; Judith White
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

6.  Human kidney cathepsins B and L. Characterization and potential role in degradation of glomerular basement membrane.

Authors:  W H Baricos; Y Zhou; R W Mason; A J Barrett
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

7.  L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L.

Authors:  A J Barrett; A A Kembhavi; M A Brown; H Kirschke; C G Knight; M Tamai; K Hanada
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

Review 8.  Cysteine cathepsins in human cancer.

Authors:  Christopher Jedeszko; Bonnie F Sloane
Journal:  Biol Chem       Date:  2004-11       Impact factor: 3.915

9.  High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation.

Authors:  Alex Crowe; Carlo Ballatore; Edward Hyde; John Q Trojanowski; Virginia M-Y Lee
Journal:  Biochem Biophys Res Commun       Date:  2007-03-19       Impact factor: 3.575

10.  Identification and characterization of 3-substituted pyrazolyl esters as alternate substrates for cathepsin B: the confounding effects of DTT and cysteine in biological assays.

Authors:  Michael C Myers; Andrew D Napper; Nuzhat Motlekar; Parag P Shah; Chun-Hao Chiu; Mary Pat Beavers; Scott L Diamond; Donna M Huryn; Amos B Smith
Journal:  Bioorg Med Chem Lett       Date:  2007-07-05       Impact factor: 2.823

View more
  6 in total

1.  A sensitive luminescent assay for the histone methyltransferase NSD1 and other SAM-dependent enzymes.

Authors:  Katherine M Drake; Venita G Watson; Anne Kisielewski; Rebecca Glynn; Andrew D Napper
Journal:  Assay Drug Dev Technol       Date:  2014-06       Impact factor: 1.738

2.  Development of a high-throughput screen for inhibitors of Epstein-Barr virus EBNA1.

Authors:  Scott Thompson; Troy Messick; David C Schultz; Melvin Reichman; Paul M Lieberman
Journal:  J Biomol Screen       Date:  2010-10

Review 3.  Pooling in high-throughput drug screening.

Authors:  Raghunandan M Kainkaryam; Peter J Woolf
Journal:  Curr Opin Drug Discov Devel       Date:  2009-05

Review 4.  The identification, characterization and optimization of small molecule probes of cysteine proteases: experiences of the Penn Center for Molecular Discovery with cathepsin B and cathepsin L.

Authors:  Donna M Huryn; Amos B Smith
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

5.  Development of a Novel Screening Strategy Designed to Discover a New Class of HIV Drugs.

Authors:  Nancy Cheng; Sook-Kyung Lee; P Scott Donover; Mel Reichman; Celia A Schiffer; Emily A Hull-Ryde; Ronald Swanstrom; William P Janzen
Journal:  J Lab Autom       Date:  2013-12-04

Review 6.  Orthogonal Drug Pooling Enhances Phenotype-Based Discovery of Ocular Antiangiogenic Drugs in Zebrafish Larvae.

Authors:  Nils Ohnesorge; Temitope Sasore; Daniel Hillary; Yolanda Alvarez; Michelle Carey; Breandán N Kennedy
Journal:  Front Pharmacol       Date:  2019-05-24       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.